Flower One Announces Hardware Partnership and Long-Term Licensing Agreement with Grenco Science, Makers of G Pen
Flower One Holdings Inc. (CSE:FONE; OTC:FLOOF) is pleased to announce a new long-term licensing agreement and partnership with leading cannabis technology and hardware brand, Grenco Science (“G Pen”). California-based Grenco Science are pioneers in the cannabis hardware space, responsible for engineering the advanced technology behind the internationally-available and ever popular G Pen line of cannabis vaporizers. Flower One is now licensed to sell, distribute and integrate G Pen’s proprietary, innovative hardware with new cannabis products from its diverse portfolio of Brand Partners.
“Flower One is pleased to partner with a leading provider of cannabis hardware, and to welcome G Pen to our growing portfolio of Brand Partners,” said Ken Villazor, President and CEO of Flower One. “This exciting partnership will allow us to further expand our cannabis offerings in the Nevada market while introducing new cannabis products, through our brand partners, that are supported by G Pen’s vaporizing technology.”
“Flower One is simply the best in the business,” said Chris Folkerts, Founder and CEO of G Pen. “This partnership will expand our ability to offer the most cutting-edge cannabis experience to Nevada’s cannabis consumers. Since we introduced the G Pen Gio, budtenders across Nevada’s dispensaries have been asking for greater brand diversity of the product. Through Flower One, we are perfectly positioned to meet the growing consumer demand for our products through a diversified and expanded product offering with their brand partners.”
Now available in Nevada, the G Pen Gio is the latest innovation in vaporizers that is revolutionizing the cannabis experience to align with a modern lifestyle. The Gio is a draw-activated concentrate vaporizer that is intuitive, portable, and accessible, and features a cutting edge cartridge system with an optimized heating temperature and integrated airpath for maximum vaporization, and consistent, smooth, and flavorful pulls.
About Flower One Holdings Inc.
Flower One is sharply focused on quickly becoming the leading cannabis cultivator, producer and innovator in the highly lucrative Nevada market. Flower One is rapidly converting its 455,000 square foot greenhouse and production facility, the largest in the State of Nevada, for the cultivation and production of high-quality cannabis at scale. It also owns and operates a 25,000 square foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and owns the established NLV Organics consumer brand of cannabis products. Combined, the flagship greenhouse and production facility and the North Las Vegas facility provide Flower One with 480,000 square feet of capacity for cultivation and processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products. Flower One is fully licensed for medical and recreational marijuana cultivation and production in the state of Nevada and currently holds licensing agreements with their Brand Partners, Flyte Concentrates, Rapid-Dose Therapeutics’ Quick Strip, Old Pal, Palms, HUXTON, CannAmerica Brands, and G Pen.
Flower One’s common shares are traded on the Canadian Securities Exchange under the symbol “FONE” and in the United States on the OTCQB under the symbol “FLOOF.” For more information visit: https://flowerone.com
About Grenco Science
Grenco Science is a leader in engineering advanced cannabis vaporizers, setting new standards in aesthetics, portability, functionality, and user experience. Through proprietary research and development, as well as collaborations with influencers in music, art, and fashion, Grenco Science is transforming the cannabis experience and leading the movement to bring cannabis traditions to the 21st century. Visit gpen.com
Cautionary Note Regarding Forward Looking Information
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Flower One’s public documents. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.
Forward-looking statements may include, without limitation, statements relating to the execution of the Company’s strategy and intent to quickly become the leading cannabis cultivator, producer and innovator in Nevada, the scale and capacity of Flower One’s cultivation, processing and high-volume packaging facilities in Nevada, Flower One’s ability to expand its cannabis offerings in Nevada or to offer the most cutting-edge cannabis experience; or Flower One’s ability to make G Pen’s product series available in Nevada, and the potential effects of G Pen’s product series.
Although Flower One has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under United States federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Flower One Holdings disclaims any intention or obligation to update or revise such information, except as required by applicable law.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR THEIR REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
For further information: Flower One Holdings Inc., Ken Villazor, President and CEO, 416.200.7641, firstname.lastname@example.org; Flower One Investor relations inquiries, NATIONAL Capital Markets, 416.848.9835, email@example.com; Flower One media inquiries, Natalie Martin, 604.738.2220, firstname.lastname@example.org; Grenco Science, Jordan Goldstein, Director of Marketing, 818.642.9890, email@example.com; Grenco Science media inquiries, Georgia Mack, 917.916.6083, firstname.lastname@example.org
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or